Through analysis of the renal cancer survival data, we revealed that patients with high expression of RBCK1 tended to achieve a shorter overall survival time, indicating that RBCK1 expression correlated with poor prognosis in RCC patients. Here, RBCK1 is linked to renal cell carcinoma.